A Phase 1 drug trial in France left one person brain-dead and five others hospitalized. The experimental medication, developed by Portuguese company Bial, was taken by healthy male individuals and was intended for mood and motor coordination issues.
A Phase 1 drug trial in France left one person brain-dead and five others hospitalized. The experimental medication, developed by Portuguese company Bial, was taken by healthy male individuals and was intended for mood and motor coordination issues.
Share this Article
Recommended